• 634 Citations
  • 15 h-Index
20052018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 19 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Waldenstrom Macroglobulinemia Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Thalidomide Medicine & Life Sciences
Epidemiology Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2018

AlternativeOutpatientChemotherapy scheduling method to improve patient service quality and nurse satisfaction

Huang, Y. L., Bryce, A. H., Culbertson, T., Connor, S. L., Looker, S. A., Altman, K. M., Collins, J. G., Stellner, W., Mc Williams, R. R., Moreno Aspitia, A., Ailawadhi, S. & Mesa, R. A., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. e82-e91

Research output: Contribution to journalArticle

Nurses
Workload
Safety
Drug Therapy
Nursing Staff

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

Ailawadhi, S., Kelly, K. R., Vescio, R. A., Jagannath, S., Wolf, J., Gharibo, M., Sher, T., Bojanini, L., Kirby, M. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Pharmacokinetics
Safety
Maximum Tolerated Dose
Drug Delivery Systems
4 Citations

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R. L., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 othersHayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cyclophosphamide
Dexamethasone
Disease-Free Survival
Bendamustine Hydrochloride

Commentary: Race and ethnicity in biomedical research - Classifications, challenges, and future directions

Idossa, D., Duma, N., Chekhovskiy, K., Go, R. & Ailawadhi, S., Sep 1 2018, In : Ethnicity and Disease. 28, 4, p. 561-564 4 p.

Research output: Contribution to journalReview article

Biomedical Research
Health
Disease Susceptibility
Ethnic Groups
Direction compound

Disease and outcome disparities in multiple myeloma: Exploring the role of race/ethnicity in the Cooperative Group clinical trials

Ailawadhi, S., Jacobus, S., Sexton, R., Stewart, A. K., Dispenzieri, A., Hussein, M. A., Zonder, J. A., Crowley, J., Hoering, A., Barlogie, B., Orlowski, R. Z. & Rajkumar, S. V., Jul 1 2018, In : Blood Cancer Journal. 8, 7, 67.

Research output: Contribution to journalArticle

Multiple Myeloma
Clinical Trials
Anemia
Therapeutics
Survival